PubRank

Forum (Genoa, Italy) (Forum (Genova))

Journal PubWeight™ 45.58‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Relationship between ideology and science. 1999 1.05
2 Hepatitis C: therapeutic perspectives. 2002 0.96
3 The molecular basis for responsiveness to anti-viral therapy in hepatitis C. 2000 0.92
4 Melanocyte development and malignant melanoma. 2001 0.87
5 Global epidemiology and medical aspects of hepatitis E. 2002 0.87
6 Angiogenesis and angiogenesis inhibitors in cancer. 1999 0.86
7 Modern aspects of radiation therapy for glial tumours of the brain. 1998 0.86
8 Hepatitis C virus: kinetics and quasispecies evolution during anti-viral therapy. 2000 0.86
9 Angiogenesis research: from laboratory to clinic. 2000 0.85
10 The role of chemokines in the immunopathology of pulmonary disease. 2000 0.85
11 G.B. Morgagni: the father and founder of contemporary pathology. 1994 0.84
12 Immunologically-mediated tumour cell apoptosis: the role of TRAIL in T cell and cytokine-mediated responses to melanoma. 2001 0.84
13 Type B and D viral hepatitis: epidemiological changes in Southern Europe. 2002 0.84
14 Melanoma antigens recognised by CD8+ and CD4+ T cells. 2001 0.84
15 Prognostic scoring systems for risk assessment in myelodysplastic syndromes. 1999 0.82
16 Brain metastases from malignant melanoma. 2003 0.81
17 Medical therapy of advanced malignant epithelial tumours of the ovary. 2001 0.81
18 A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4. 2000 0.81
19 Retracted Xenotransplantation: state of the art. 2000 0.81
20 Heparin and nitric oxide treatment in experimental acute pancreatitis in rats. 1998 0.81
21 Guidelines for the treatment of primary central nervous system lymphomas in immunocompetent patients. 2003 0.80
22 Gastric cancer: epidemiologic and biological aspects. 1999 0.79
23 The use of gene transfer in cancer immunotherapy. 1999 0.79
24 Current and future strategies in the management of medulloblastoma in adults. 2003 0.78
25 Pathophysiology, clinical manifestations and supportive care of metastatic brain cancer. 2001 0.78
26 New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance. 2001 0.78
27 Medical treatment of brain metastases from solid tumours. 2000 0.78
28 Interferon and ribavirin combination therapy: indications and schedules. 2000 0.78
29 Haematological disorders in liver disease. 1998 0.78
30 Primary breast lymphoma. 1999 0.78
31 Chemotherapy in the elderly with breast cancer. 2002 0.78
32 Prognostic factors in patients with brain metastases. 2001 0.77
33 Control of dendritic cell migration by chemokines. 2000 0.77
34 Adjuvant high-dose interferon-alpha therapy for high-risk melanoma. 2003 0.77
35 Gene-environment interaction in melanoma. 2001 0.77
36 Genetics of kidney tumours. 1999 0.77
37 Melanoma vaccines: achievements and perspectives. 2003 0.77
38 Recent advances in our understanding of the biology and pathogenesis of gastric mucosa-associated lymphoid tissue (malt) lymphoma. 1999 0.77
39 Radiotherapy in epithelial ovarian cancer: state of the art. 2001 0.77
40 Thyrotropin receptor: a role for thyroid tumourigenesis? 1999 0.77
41 Guidelines for the treatment of oligodendroglioma: an evidence-based medicine approach. 2003 0.77
42 Early-stage epithelial ovarian cancer: an overview. 2001 0.77
43 Cytokine-based therapy for melanoma: pre-clinical studies. 2001 0.77
44 Classification and biology of astrocytic gliomas. 1998 0.76
45 Predictors of response to systemic therapy in breast cancer. 2002 0.76
46 New frontiers in therapy of malignant gliomas. 1998 0.76
47 New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer. 2002 0.76
48 Update on the role of adjuvant interferon for high risk melanoma. 2001 0.76
49 Controversies in the management of multiple brain metastases: the roles of radiosurgery and radiation therapy. 2001 0.76
50 Genetic testing in multiple endocrine neoplasia and related syndromes. 1999 0.76
Next 50